The first head-to-head trial of Mounjaro and Wegovy found that the former was more effective.
Mounjaro’s 20% weight reduction, after 72 weeks of treatment, exceeded the 14% for Wegovy.
The trial – funded by Mounjaro manufacturer Eli Lilly – involved 750 obese people, with an average weight of 113kg (nearly 18 stone).
